Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism PARP7 modulators(TCDD-inducible poly [ADP-ribose] polymerase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | United States | 01 Oct 2025 | |
Neoplasms | Preclinical | United States | 01 Jan 2025 |